PIRAMAL PHARMA
Back to Income Statement
|
PIRAMAL PHARMA Last 5 Year Consolidated Net Profit History
[Consolidated]
| Mar2026 | Mar2025 | Mar2024 | Mar2023 | Mar2022 | |
|---|---|---|---|---|---|
| Consolidated Net Profit | ₹-326 Cr | ₹91 Cr | ₹18 Cr | ₹-186 Cr | ₹376 Cr |
What is the latest Consolidated Net Profit of PIRAMAL PHARMA ?
| Year | Consolidated Net Profit |
|---|---|
| Mar2026 | ₹-326 Cr |
| Mar2025 | ₹91 Cr |
| Mar2024 | ₹18 Cr |
| Mar2023 | ₹-186 Cr |
| Mar2022 | ₹376 Cr |
How is Consolidated Net Profit of PIRAMAL PHARMA Trending?
| Years | Consolidated Net Profit | % Change | |
|---|---|---|---|
| Mar2026 | ₹-326 Cr | Negative | |
| Mar2025 | ₹91 Cr | 411.39 | |
| Mar2024 | ₹18 Cr | Positive | |
| Mar2023 | ₹-186 Cr | Negative | |
| Mar2022 | ₹376 Cr | - | |
Compare Consolidated Net Profit of peers of PIRAMAL PHARMA
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| PIRAMAL PHARMA | ₹29,102.2 Cr | 3.5% | 11.1% | 11.5% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹460,696.0 Cr | 0.5% | -4% | 15.7% | Stock Analytics | |
| DIVIS LABORATORIES | ₹246,063.0 Cr | 9.1% | 18.2% | 47.1% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹191,515.0 Cr | 3.6% | 3.4% | 36.4% | Stock Analytics | |
| CIPLA | ₹114,554.0 Cr | -1.2% | -3.3% | -10.8% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹98,308.6 Cr | -1.4% | 2.9% | -8% | Stock Analytics | |
PIRAMAL PHARMA Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| PIRAMAL PHARMA | 3.5% |
11.1% |
11.5% |
| SENSEX | -0.4% |
-0.5% |
-5.8% |
You may also like the below Video Courses